Skip to content

Clinical and Mechanistic Study on the Association Between Platelet Activation During Cardiopulmonary Bypass Cardiac Surgery and Postoperative Delirium

Clinical and Mechanistic Study on the Association Between Platelet Activation During Cardiopulmonary Bypass Cardiac Surgery and Postoperative Delirium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123349
Enrollment
Unknown
Registered
2026-04-24
Start date
2026-04-25
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium (POD)

Interventions

POD-High risk:None
POD-low risk:None

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. Elective major cardiac or great vessel surgery requiring cardiopulmonary bypass (CPB); 3. Normal preoperative cognitive function, defined as Mini-Mental State Examination (MMSE) score >=24; 4. Expected cardiopulmonary bypass duration >=1 hour.

Exclusion criteria

Exclusion criteria: 1. Patients with a preoperative MMSE score <24; 2. Patients with a history of severe psychiatric disorders or epilepsy; 3. Patients who received high-dose glucocorticoids or immunosuppressive/biologic therapy within 14 days before surgery; 4. Patients with ALT, AST, or total bilirubin (TBi) exceeding three times the upper limit of normal; 5. Patients with serum creatinine exceeding twice the upper limit of normal; 6. Pregnant or breastfeeding women; 7. Patients with known platelet function disorders; 8. Patients unwilling to participate in the study or unable to provide informed consent; 9. Patients unable to undergo CAM-ICU assessment within 24–72 hours postoperatively for any reason.

Design outcomes

Primary

MeasureTime frame
Baseline platelet activation level;Platelet response to ADP;CAM-ICU–based delirium assessment outcomes;

Secondary

MeasureTime frame
Core temperature;Intraoperativebloodtransfusion;5-HT;IL-6;Platelet metabolites detected by LC-MS;Preoperative use of antiplatelet drugs;TXA2;MAP;

Countries

China

Contacts

Public ContactWu Jingxiang

Shanghai Chest Hospital

wjx1132@163.com+86 21 2220 0000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026